MCRC trial

The clinical trials site was updated today. The trial title is now called CLOVER--CCR5-targeting Leronlimab With Oral Chemotherapy and VEGF-inhibitor Enriched Regimen Trial (CLOVER)

#1--Nearly all the wording in the trial that previously had CCR5+, that has been removed

#2--Georgetown Univ Med Center has been added as a trial site

#3--several secondary outcome measures were added. Prev there were 2--now there are 7

#4--there are now "Other Outcome Measures"--there are 5 in total. Prev there were none

https://clinicaltrials.gov/study/NCT06699836

For some that are not familiar--#1 go to the trial website--#2 then choose "record history"--#3--select the 2 versions (dates) you want to compare--#4--select "COMPARE"--#5 choose side by side or merged to view changes between the 2 selected records